Value
- Base
- 18.50
- Cagr
- 9.27
- Currency
- USD
- Forecast
- 37.59
- Unit
- Billion
Graph-backed node
The Connected Glucose Monitoring Device market is expected to experience strong growth during the forecast period from 2026 to 2033. Valued at USD 18.50 billion in 2025, the market is projected to expand at a compound annual growth rate (CAGR) of 9.27%, reaching approximately USD 37.59 billion by 2033. This growth reflects the increasing adoption of advanced, connected technologies that enhance accessibility, efficiency, and integration within broader digital health ecosystems.
The Connected Glucose Monitoring Device market is expected to experience strong growth during the forecast period from 2026 to 2033. Valued at USD 18.50 billion in 2025, the market is projected to expand at a compound annual growth rate (CAGR) of 9.27%, reaching approximately USD 37.59 billion by 2033. This growth reflects the increasing adoption of advanced, connected technologies that enhance accessibility, efficiency, and integration within broader digital health ecosystems.
The market is forecasted to reach USD 37.59 billion by the end of 2033.
The market is expected to expand at a CAGR of 9.26%.
Key players include Dexcom, Medtronic, Abbott, and Roche.
Applications include type 1 diabetes management, type 2 diabetes management, and gestational diabetes monitoring.
Environment: live
Freshness: 2026-06-12T19:44:36+00:00
Resolved node: MIMR-node_a3d6d2d
Statsfocus
https://statsfocus.com
Knowledge graph of market intelligence